IP Library Granted Patent US 10,792,363
Granted Patent B2
US 10,792,363 · App. 16/458,261 · Granted Oct 6, 2020

Anhydrous sodium thiosulfate and formulations thereof

Inventors: Thomas Claiborne Lovelace (Apex, NC); Joseph Alexander Moore, III (Wake Forest, NC); Christopher McKinnon Lee (Holly Springs, NC); Daniel Logan Kirschner (Raleigh, NC)
Assignee: FENNEC PHARMACEUTICALS, INC.
A61K47/20A61K9/0019A61K9/08A61K33/04A61K33/243A61K47/02A61K47/18A61K47/183
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,792,363
App. No.
16/458,261
Granted
Oct 6, 2020
Kind
B2
Abstract

Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum based chemotherapeutics.

Claims (53)

1. Anhydrous sodium thiosulfate characterized by an X-ray powder diffraction (XRPD) pattern comprising at least four peaks selected from 10.52, 15.13, 17.71, 19.70, 21.09, 21.49, 21.84, 27.40, 28.96, 30.46, 31.81, 32.52, 33.15, 37.40, or 38.16 degrees 2 theta (2 θ)±0.2, when the XRPD is collected from about 2 to about 40 degrees 2 θ using copper Kα radiation.

2. The anhydrous sodium thiosulfate of claim 1 , wherein the anhydrous sodium thiosulfate is characterized by an X-ray powder diffraction (XRPD) pattern comprising at least four peaks selected from 10.52, 15.13, 19.70, 21.49, 21.84, 28.96, 30.46, 33.15, 37.40, and 38.16 degrees 2 theta (2 θ)±0.2, when the XRPD is collected from about 2 to about 40 degrees 2 θ using copper Kα radiation.

3. The anhydrous sodium thiosulfate of claim 1 , wherein the anhydrous sodium thiosulfate is characterized by a differential scanning calorimetry melting onset of about 331° C.; and a thermogravimetric analysis showing negligible weight loss from ambient temperature to 162° C., a weight loss of 14.8% from 162° C. to 309° C., and an onset of decomposition at 436° C.

4. Anhydrous sodium thiosulfate comprising:

no greater than 0.1 μg/g of cadmium;

no greater than 0.25 μg/g lead;

no greater than 0.75 μg/g arsenic;

no greater than 0.15 μg/g mercury;

no greater than 0.25 μg/g cobalt;

no greater than 0.5 μg/g vanadium;

no greater than 1.0 μg/g nickel;

no greater than 12.5 μg/g lithium;

no greater than 4.5 μg/g antimony;

no greater than 15.0 μg/g copper;

no greater than 1500 ppm methanol;

no greater than 3% (w/w) water; and

no greater than 1.65% (w/w) of total impurities or related substances.

5. A method for synthesizing anhydrous sodium thiosulfate comprising:

reacting sodium sulfite with sulfur in the presence of a surface acting agent; and

crystallizing the product with an acetone wash.

6. The method of claim 5 , wherein the surface acting agent comprises cetylpyridinium chloride.

7. The method of claim 5 , wherein the reaction is aqueous.

8. The method of claim 5 , wherein the reaction is conducted at about 80° C. to about 100° C.

9. A method for synthesizing anhydrous sodium thiosulfate comprising reacting sodium sulfite with sulfur in the presence of cetylpyridinium chloride and dehydrating sodium thiosulfate product.

10. The method of claim 9 , wherein the reaction comprises 1.0 mole equivalent of sodium sulfite; 1.1 mole equivalents of sulfur; and 0.00013 mole equivalents of cetylpyridinium chloride.

11. The method of claim 9 , wherein the reaction is aqueous.

12. The method of claim 9 , wherein the reaction is conducted at about 80° C. to about 100° C.

13. The method of claim 9 , wherein the sodium thiosulfate is crystallized and washed with acetone.

14. The method of claim 9 , wherein the sodium thiosulfate is dehydrated and washed with methanol.

15. The method of claim 9 , wherein the sodium thiosulfate is dried.

16. A method for synthesizing anhydrous sodium thiosulfate comprising:

(a) reacting aqueous sodium sulfite with sulfur and cetylpyridinium chloride;

(b) crystallizing sodium thiosulfate and washing with acetone;

(c) dehydrating the washed sodium thiosulfate with methanol; and

(d) drying the dehydrated sodium thiosulfate.

17. The method of claim 16 , wherein the reaction comprises 1.0 mole equivalent of sodium sulfite; 1.1 mole equivalents of sulfur; and 0.00013 mole equivalents of cetylpyridinium chloride.

18. A method for synthesizing anhydrous sodium thiosulfate comprising:

(a) reacting 1.0 mole equivalent of aqueous sodium sulfite with 1.1 mole equivalents of sulfur in the presence of 0.00013 mole equivalents of cetylpyridinium chloride at about 90° C. to about 100° C.;

(b) crystallizing sodium thiosulfate at <2° C. and washing with acetone;

(c) dehydrating the washed sodium thiosulfate with methanol; and

(d) drying the dehydrated sodium thiosulfate at about 25° C. to about 60° C.

19. Anhydrous sodium thiosulfate synthesized by the method of claim 18 .

20. Means for synthesizing anhydrous sodium thiosulfate comprising reacting sodium sulfite with sulfur in the presence of cetylpyridinium chloride, crystallizing the sodium thiosulfate product, and dehydrating sodium thiosulfate product.

21. Anhydrous sodium thiosulfate synthesized by the means of claim 20 .

22. A method for measuring the binding capacity of sodium thiosulfate for cisplatin comprising:

(a) mixing one or more mole ratios of sodium thiosulfate with a predetermined quantity of cisplatin;

(b) incubating the mixture for a period of time; and

(c) analyzing the apparent concentration of cisplatin.

23. The method of claim 22 , wherein the mole ratios of sodium thiosulfate to cisplatin comprise 10:1 to 1:1.

24. The method of claim 22 , wherein the mole ratios of sodium thiosulfate to cisplatin comprise 10:1, 6:1, and 5:1.

25. The method of claim 22 , wherein the incubation period of time comprises 1 min to 180 min.

26. The method of claim 22 , wherein the incubation period of time comprises about 5 min; about 35 min, about 65 min; and about 95 min.

27. The method of claim 22 , wherein the analyzing comprises HPLC and UV detection.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2024
From: SMITH, ALEXANDER
To: ADS PHARMA CONSULTING, LLC
Reel/Frame 066137/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2024
From: ADS PHARMA CONSULTING, LLC
To: FENNEC PHARMACEUTICALS, INC.
Reel/Frame 066137/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: LOVELACE, THOMAS CLAIBORNE; MOORE, JOSEPH ALEXANDER, III; LEE, CHRISTOPHER MCKINNON; KIRSCHNER, DANIEL LOGAN
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 053429/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: AVISTA PHARMA SOLUTIONS, INC.
To: FENNEC PHARMACEUTICALS, INC.
Reel/Frame 053429/0537 →
Continuity (3)
Provisional Application 62693502 · Jul 3, 2018
Provisional Application 62693503 · Jul 3, 2018
Related Publication 20200009255A1 · Jan 9, 2020
Cited By (2)
US 12,311,026 US 12,454,476